HU9301726D0 - Compounds and preparatives hindering resorption of bones - Google Patents

Compounds and preparatives hindering resorption of bones

Info

Publication number: HU9301726D0
Authority: HU; Hungary
Prior art keywords: pct; preparatives; resorption; hindering; bones
Prior art date: 1990-12-13

Application number

HU931726A

Other languages

English (en)

Other versions

HUT64565A (en

Inventor

Bruce Ernest Kemp

Geoffrey Charles Nicholson

Thomas J Martin

Anna Jane Fenton

Glenn R Hammonds

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-13

Filing date

1991-12-13

Publication date

1993-10-28

1991-12-13 Application filed by Genentech Inc filed Critical Genentech Inc

1993-10-28 Publication of HU9301726D0 publication Critical patent/HU9301726D0/hu

1994-01-28 Publication of HUT64565A publication Critical patent/HUT64565A/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Transceivers (AREA)
Mobile Radio Communication Systems (AREA)

HU9301726A 1990-12-13 1991-12-13 Method for producing compounds and preparatives inhibiting resorption of bones HUT64565A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPK387990		1990-12-13
AUPK956791		1991-11-19

Publications (2)

Publication Number	Publication Date
HU9301726D0 true HU9301726D0 (en)	1993-10-28
HUT64565A HUT64565A (en)	1994-01-28

Family

ID=25643990

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9301726A HUT64565A (en)	1990-12-13	1991-12-13	Method for producing compounds and preparatives inhibiting resorption of bones

Country Status (12)

Country	Link
US (1)	US5688760A (hu)
EP (1)	EP0561877B1 (hu)
JP (1)	JP3280021B2 (hu)
AT (1)	ATE181336T1 (hu)
AU (1)	AU666838B2 (hu)
CA (1)	CA2096933C (hu)
DE (1)	DE69131355T2 (hu)
DK (1)	DK0561877T3 (hu)
ES (1)	ES2135398T3 (hu)
GR (1)	GR3030947T3 (hu)
HU (1)	HUT64565A (hu)
WO (1)	WO1992010511A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2158762A1 (en) *	1993-04-08	1994-10-27	Hans Rink	Cyclic compounds and compositions which inhibit bone resorption
GB9425582D0 (en) *	1994-12-19	1995-02-15	Iaf Biochem Int	Peptides having immunomodulatory activity
EP0811383B1 (en) *	1995-02-20	2007-05-30	Yukio Kato	Remedies for arthrosis deformans and inflammatory joint diseases
AU686937B2 (en) *	1995-03-20	1998-02-12	Shell Internationale Research Maatschappij B.V.	Process for catalyst regeneration
EP0902036A1 (en) *	1997-09-05	1999-03-17	Roche Diagnostics GmbH	Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
EP1062229A1 (en) *	1998-03-09	2000-12-27	Zealand Pharmaceuticals A/S	Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
JP2005525312A (ja) *	2002-01-10	2005-08-25	オステオトロフィンエルエルシー	骨同化物質を用いた骨疾患の治療方法
JP2006508646A (ja) *	2002-08-15	2006-03-16	バスキュロスタティンエルエルシー	ＰＴＨｒＰ由来の平滑筋増殖モジュレータ
RU2010114039A (ru) *	2007-09-11	2011-10-20	Мондобайотек Лабораториз Аг (Li)	Применение октреотида в качестве терапевтического средства
ES2605813B1 (es) *	2015-09-16	2018-01-17	Fundación Instituto De Investigación Sanitaria Fundación Jiménez Díaz	Uso de osteostatina en la preparación de un medicamento para el tratamiento de artrosis
EP4218784A3 (en) *	2017-05-22	2023-09-13	National Hellenic Research Foundation	Macrocyclic modulators of disease associated protein misfolding and aggregation
WO2024238631A2 (en) *	2023-05-15	2024-11-21	Purdue Research Foundation	A cytokine-like propeptide gene therapy platform

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL78342A (en) *	1985-04-04	1991-06-10	Gen Hospital Corp	Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
JPS63259972A (ja) *	1987-04-17	1988-10-27	Fuji Electric Co Ltd	燃料電池設備
US5312810A (en) *	1987-05-20	1994-05-17	The University Of Melbourne	Method and compositions for making ACSF and ACSF antagonists
JP2795657B2 (ja) *	1987-05-20	1998-09-10	ジェネンテク，インコーポレイテッド	Ａｃｓｆおよびａｃｓｆアンタゴニストの製造方法および組成物
US4819504A (en) *	1987-05-27	1989-04-11	Sampson Sports, Inc.	Self contained braking system for bicycle pedals
DE68921665T2 (de) *	1988-05-09	1995-09-21	Merck & Co Inc	Hemmer vom flüssigen kalziumerhöhenden Faktor.
JP2752987B2 (ja) *	1988-06-01	1998-05-18	株式会社東芝	リン酸型燃料電池発電プラント

1991
- 1991-12-13 DK DK92900438T patent/DK0561877T3/da active
- 1991-12-13 CA CA002096933A patent/CA2096933C/en not_active Expired - Lifetime
- 1991-12-13 DE DE69131355T patent/DE69131355T2/de not_active Expired - Lifetime
- 1991-12-13 US US08/064,111 patent/US5688760A/en not_active Expired - Lifetime
- 1991-12-13 AT AT92900438T patent/ATE181336T1/de not_active IP Right Cessation
- 1991-12-13 HU HU9301726A patent/HUT64565A/hu unknown
- 1991-12-13 JP JP50160992A patent/JP3280021B2/ja not_active Expired - Lifetime
- 1991-12-13 WO PCT/AU1991/000580 patent/WO1992010511A1/en active IP Right Grant
- 1991-12-13 AU AU90632/91A patent/AU666838B2/en not_active Expired
- 1991-12-13 ES ES92900438T patent/ES2135398T3/es not_active Expired - Lifetime
- 1991-12-13 EP EP92900438A patent/EP0561877B1/en not_active Expired - Lifetime
1999
- 1999-08-10 GR GR990402028T patent/GR3030947T3/el unknown

Also Published As

Publication number	Publication date
CA2096933C (en)	2003-05-13
DE69131355D1 (de)	1999-07-22
JP3280021B2 (ja)	2002-04-30
AU666838B2 (en)	1996-02-29
DE69131355T2 (de)	1999-12-30
JPH06503330A (ja)	1994-04-14
GR3030947T3 (en)	1999-11-30
EP0561877A1 (en)	1993-09-29
AU9063291A (en)	1992-07-08
DK0561877T3 (da)	1999-12-27
US5688760A (en)	1997-11-18
WO1992010511A1 (en)	1992-06-25
CA2096933A1 (en)	1992-06-14
EP0561877B1 (en)	1999-06-16
HUT64565A (en)	1994-01-28
ATE181336T1 (de)	1999-07-15
EP0561877A4 (hu)	1994-03-23
ES2135398T3 (es)	1999-11-01

Similar Documents

Publication	Publication Date	Title
RU2224539C2 (ru)	2004-02-27	Заживление переломов с помощью аналогов пептида, подобного паратироидному гормону (ртнrр)
IL112112A0 (en)	1995-03-15	Peptide derivatives and pharmaceutical compositions containing them
MX9703643A (es)	1997-08-30	Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
NZ248377A (en)	2000-01-28	Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors
DE3851776D1 (de)	1994-11-17	Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
HU9301726D0 (en)	1993-10-28	Compounds and preparatives hindering resorption of bones
ATE116335T1 (de)	1995-01-15	Peptid-analoge vom insulinähnlichen wachstums- faktor 1 (igf-1) oder faktor 2 (igf-2).
DE59407237D1 (de)	1998-12-10	Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
BG104544A (en)	2001-03-30	Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
AU6020099A (en)	2000-03-14	Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
ATE377026T1 (de)	2007-11-15	Behandlung von fettleibigkeit
ATE213499T1 (de)	2002-03-15	Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
GR3026600T3 (en)	1998-07-31	Human il-4 mutant proteins.
ES2139081T3 (es)	2000-02-01	Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
DK0687270T3 (da)	2000-10-30	Osteogene vækstoligopeptider og farmaceutiske præparater indeholdende disse
DE69102069D1 (de)	1994-06-23	5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
SE9403055D0 (sv)	1994-09-13	A new human peptide antibiotic (FALL-39) and its use
IL88726A0 (en)	1989-07-31	Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
DE3462692D1 (en)	1987-04-23	Pharmacologically active peptides
KR950704358A (ko)	1995-11-20	카텝신 l 특이적 저해 폴리펩티드
ATE153859T1 (de)	1997-06-15	Somatotropin zur erhoehung der reproduktiven leistung in rinder
KR920700224A (ko)	1992-02-19	신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
AR002956A1 (es)	1998-05-27	Proteinas utiles para el tratamiento de la obesidad y de trastornos relacionados con ella, proceso para obtenerlas y composiciones farmaceuticasque las contienen.
MX9800686A (es)	1998-10-31	Nueva proteina hmw humana mp52s.

Legal Events

Date	Code	Title	Description
1999-07-28	DFC4	Cancellation of temporary protection due to refusal